AVITA Therapeutics, Inc. (RCEL) CEO Mike Perry on Q2 2021 Results - Earnings Call Transcript

AVITA Therapeutics, Inc. (NASDAQ:RCEL) Q2 2021 Earnings Conference Call February 11, 2021 4:30 PM ET

Company Participants

Caroline Corner - Investor Relations, Westwicke
Mike Perry - Chief Executive Officer
Sean Ekins - Interim Principal Financial Officer and Accounting Officer
Erin Liberto - Chief Commercial Officer
Andrew Quick - Chief Technology Officer

Conference Call Participants

Josh Jennings - Cowen
Kevin DeGeeter - Oppenheimer & Co
Ryan Zimmerman - BTIG
Brooks O'Neil - Lake Street Capital Markets
Lyanne Harrison - Bank of America
John Hester - Bell Potter

Operator

Ladies and gentlemen, thank you for standing by. And welcome to the AVITA Medical Second Quarter Earnings Conference Call. [Operator Instructions] Please be advised that today's conference maybe record.

I'd now like to hand the conference over to your speaker today, Ms. Caroline Corner with Westwicke. Please go ahead ma'am.

Caroline Corner

Thank you, operator. Welcome to AVITA Medical's first fiscal second quarter 2021 earnings call. Joining me on today's call are Mike Perry, President and Chief Executive Officer; and Sean Ekins, Interim, Principal Financial Officer and Principal Accounting Officer.

This call will include forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. All statements made on this call that do not relate to matters of historical fact should be considered forward-looking statements, including statements regarding the markets in which AVITA operates, trends and expectations for AVITA's products and technology, trends and demand for AVITA's products, AVITA's expected financial performance, expenses and position in the market and the impact of COVID-19 on AVITA's operations and AVITA's customers' operations. These statements are neither promises nor guarantees and involve known and unknown risks and uncertainties that could cause actual results, performance or achievements to differ materially from any results, performance, or achievements expressed or implied by the forward-looking statements.

Please